Form 10-Q · Quarterly report
PulteGroup 10-Q, filed Oct 22, 2026
- Filed
- CIK
- 0000822416
- Accession no.
- 0000822416-26-000043
Summary
PulteGroup reported third-quarter 2026 net income of $475.7 million, or $2.53 per diluted share, down from $585.8 million, or $2.96 per share, a year earlier, as elevated mortgage rates and affordability pressures weighed on housing demand. Net new orders fell 6% in units, closings fell 9%, and home sale gross margin declined to 24.8% from 26.2%, while the company continued share repurchases and raised its quarterly dividend.
Key points
- Third-quarter 2026 net income was $475.7 million, or $2.53 per diluted share, compared with $585.8 million, or $2.96 per diluted share, in the third quarter of 2025.
- Net new orders decreased 6% in units to 6,208, closings decreased 9% to 6,876, and average selling price decreased 1%.
- Home sale gross margin fell to 24.8% in the third quarter of 2026 from 26.2% a year earlier.
- PulteGroup repurchased $1.0 billion of shares in the first nine months of 2026 and increased its quarterly dividend 18%, from $0.22 to $0.26 per share, effective with the January 2026 dividend payment.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations The following discussion and analysis of our financial condition and results of operations is provided as a supplement to and should be read in conjunction with the consolidated financial statements and related notes included elsewhere in this Quarterly Report on Form 10-Q as well as our audited consolidated financial statements and related notes included in our Annual Report on Form 10-K for the year ended December 31, 2025. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.